Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia

Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia

In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as a standard of care. Nevertheless, controversial reports have been published. The aim of the present study is to evaluate...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Vasilis Petrakis, Vasiliki Rapti, Karolina Akinosoglou, Constantinos Bonelis, Kalomoira Athanasiou, Vasiliki Dimakopoulou, Nikolaos K. Syrigos, Nikolaos Spernovasilis, Grigoris Trypsianis, Markos Marangos, Charalambos Gogos, Dimitrios Papazoglou, Periklis Panagopoulos, Garyfallia Poulakou
التنسيق: مقال
اللغة:English
منشور في: MDPI AG 2022-09-01
سلاسل:Microorganisms
الموضوعات:
remdesivir
COVID-19
SARS-CoV-2
pandemic
retrospective study
intubation
الوصول للمادة أونلاين:https://www.mdpi.com/2076-2607/10/10/1949

الانترنت

https://www.mdpi.com/2076-2607/10/10/1949

مواد مشابهة